Vincenzo D. Boccia - Publications

Primary Brain Calcification Associated with a Novel XPR1 In-Frame Deletion: Clinical Characterization and Insights into Cerebellar and Basal Ganglia Contributions.

Journal: Cerebellum (London, England)

Published: March 19, 2026

Short-term effects of ocrelizumab on cortical pathology in patients with multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: February 13, 2026

Subthalamic versus Posterior Subthalamic Stimulation for Optimal Tremor Control in Parkinson's Disease.

Journal: Stereotactic and functional neurosurgery

Published: October 06, 2025

Safety and Efficacy of Focused Ultrasound Thalamotomy in Elderly Patients: A Single-Center Cohort Study.

Journal: Movement disorders clinical practice

Published: September 26, 2025

Increased Visual Response Delay Impact on Sensorimotor Control in Persons With Multiple Sclerosis.

Journal: IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society

Published: June 04, 2025

Observation of Collider Neutrinos without Final State Muons with the SND@LHC Experiment.

Journal: Physical review letters

Published: November 30, 2024

The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod.

Journal: Multiple sclerosis and related disorders

Published: October 01, 2024

Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: October 01, 2024

HSCT for stiff person syndrome and myasthenia gravis.

Journal: Handbook of clinical neurology

Published: August 07, 2024

Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.

Journal: PloS one

Published: April 17, 2024

Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease.

Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging

Published: April 17, 2024

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.

Journal: Annals of clinical and translational neurology

Published: March 15, 2024